Piramal Pharma Q3 FY24 results : profit at ₹10.11Cr, Revenue increased by 14.14% YoY

Piramal Pharma Q3 FY24 results : Revenue increased by 14.14% YoY & profit at 10.11Cr

Livemint
First Published1 Feb 2024, 02:22 AM IST
Piramal Pharma Q3 FY24 Results Live
Piramal Pharma Q3 FY24 Results Live

Piramal Pharma declared their Q3 FY24 results on 30 Jan, 2024. The topline increased by 14.14% & the profit came at 10.11cr. It is noteworthy that Piramal Pharma had declared a loss of 90.18cr in the previous fiscal year same period. As compared to the previous quarter, the revenue grew by 2.47%.

The Selling, general & administrative expenses rose by 1.5% q-o-q & increased by 6.41% Y-o-Y.

The operating income was down by 3.17% q-o-q & increased by 16.65% Y-o-Y.

The EPS is 0.21 for Q3 FY24, which increased by 128.75% Y-o-Y.

Piramal Pharma has delivered -3.2% return in the last 1 week, 33.71% return in the last 6 months, and 0.11% YTD return.

Currently, Piramal Pharma has a market cap of 18319.52 Cr and a 52wk high/low of 148.7 & 61.62 respectively.

As of 01 Feb, 2024, out of 4 analysts covering the company, 4 analysts have given a Strong Buy rating.

The consensus recommendation as of 01 Feb, 2024, was to Strong Buy.

Piramal Pharma Financials

PeriodQ3 FY24Q2 FY24Q-o-Q GrowthQ3 FY23Y-o-Y Growth
Total Revenue1958.571911.38+2.47%1715.97+14.14%
Selling/ General/ Admin Expenses Total523.78516.03+1.5%492.23+6.41%
Depreciation/ Amortization186.32184.51+0.98%164.43+13.31%
Total Operating Expense1356.011289.08+5.19%1199.43+13.05%
Operating Income602.56622.3-3.17%516.54+16.65%
Net Income Before Taxes19.3639.56-51.06%-73.64+126.29%
Net Income10.115.02+101.39%-90.18+111.21%
Diluted Normalized EPS0.210.04+433.38%-0.74+128.75%
Stay updated on quarterly results with our results calendar

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.MoreLess
FAQs
<span class='webrupee'>₹</span>10.11Cr
<span class='webrupee'>₹</span>1958.57Cr
First Published:1 Feb 2024, 02:22 AM IST
HomeCompaniesCompany ResultsPiramal Pharma Q3 FY24 results : profit at ₹10.11Cr, Revenue increased by 14.14% YoY

Most Active Stocks

Indian Oil Corporation

166.90
03:58 PM | 12 JUL 2024
-7.6 (-4.36%)

Tata Steel

168.70
03:58 PM | 12 JUL 2024
-0.3 (-0.18%)

Bharat Electronics

333.30
03:59 PM | 12 JUL 2024
-2.25 (-0.67%)

Wipro

560.05
03:56 PM | 12 JUL 2024
25.7 (4.81%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

KPIT Technologies

1,864.00
03:57 PM | 12 JUL 2024
154.25 (9.02%)

Inox Wind

171.90
03:59 PM | 12 JUL 2024
13.85 (8.76%)

Zensar Technologies

768.20
03:29 PM | 12 JUL 2024
50.45 (7.03%)

Coforge

5,950.05
03:29 PM | 12 JUL 2024
386.65 (6.95%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K
    Bangalore
    74,481.00218.00
    Chennai
    73,972.00-727.00
    Delhi
    74,771.00-218.00
    Kolkata
    73,972.00-218.00

    Fuel Price

    • Petrol
    • Diesel
    Bangalore
    102.86/L0.00
    Chennai
    100.76/L0.01
    Kolkata
    104.95/L0.00
    New Delhi
    94.72/L0.00
    OPEN IN APP
    HomeMarketsCibilPremiumMint Shorts